Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances
ID: 355904Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$350K - $475K

Eligible Applicants

For-Profit Organizations

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355904
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances." This initiative aims to support pilot research focused on developing and testing behavioral implementation strategies for biomedical interventions, such as oral PrEP and condom use, to enhance HIV and STI prevention among disproportionately affected populations, particularly Black and Hispanic men who have sex with men (MSM) who report substance use. The funding, totaling $2.85 million, is intended for a three-year performance period, with two awards expected, each ranging from $350,000 to $475,000. Interested applicants must submit their proposals by February 20, 2025, with the project anticipated to commence on September 1, 2025. For further inquiries, applicants can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.

    Point(s) of Contact
    JPatterson@cdc.gov
    Files
    Title
    Posted
    RFA-PS-25-113_20241216.pdf
    The Centers for Disease Control and Prevention (CDC) has issued a Notice of Funding Opportunity (NOFO) aimed at developing and testing HIV prevention interventions specifically for Black and Hispanic men who have sex with men (MSM) who use substances. Identified as RFA-PS-25-113, this initiative seeks to address significant health disparities in HIV infection rates within these populations. A total of $2.85 million is allocated for a three-year performance period, with two awards expected, each supporting the development and evaluation of culturally competent strategies that enhance PrEP (Pre-exposure prophylaxis) adherence and condom use. The funding allows eligible institutions to conduct research that meets CDC's Best Evidence framework, focusing on encouraging sexual protective behaviors in priority jurisdictions outlined in the “Ending the HIV Epidemic” (EHE) initiative. Applications are encouraged from various organizations, with a strong emphasis on partnerships with community-based groups and health departments. The project aims to assess and potentially expand successful interventions into officially endorsed programs for widespread community implementation, thereby contributing to national goals for reducing HIV infections. The application deadline is set for February 20, 2025, with an intended start date of September 1, 2025.
    Similar Opportunities
    Implementation and Evaluation of PrEPmate: An evidence-based short message service/text-based PrEP intervention for YMSM and Transgender women of color
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the implementation and evaluation of PrEPmate, a mobile health intervention aimed at enhancing HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) and transgender women of color. The initiative seeks to facilitate the deployment of PrEPmate at three clinical sites in the southern United States, focusing on improving patient adherence and retention in PrEP care through tailored interactive content, reminders, and a monitoring dashboard. With an estimated total program funding of $3 million and one expected award, interested applicants can reach out to Charles Collins at cwc4@cdc.gov or by phone at 404-639-0966. The application deadline is set for March 7, 2025, with project commencement anticipated on July 1, 2025.
    PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a funding opportunity titled "PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention." This initiative aims to support an implementation research study that evaluates strategies for integrating Postexposure Prophylaxis (PEP) packs into existing Pre-exposure Prophylaxis (PrEP) services, specifically targeting populations disproportionately affected by HIV, such as Black and Hispanic men who have sex with men (MSM) and transgender women (TGW). The program seeks to enhance access to nonoccupational PEP (nPEP) and includes the provision of starter kits containing nPEP medications, STI prophylaxis treatment, and self-testing kits to facilitate immediate prevention following potential exposures. The total funding available for this opportunity is $4.8 million, with a single award anticipated, and applications must be submitted electronically by February 19, 2025. For further inquiries, interested parties can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.
    Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South." This initiative aims to address the significant health disparities faced by CgBW, who represent the largest percentage of women living with HIV in the U.S., by funding organizations to implement integrated care service models through Community and Clinic Collaboratives (CCCs). The project will focus on providing comprehensive health services, including HIV care, mental health support, and essential services, while fostering culturally responsive practices and sharing best practices through a national learning collaborative. The estimated total program funding is $7.5 million, with three awards expected, and applications must be submitted electronically by March 28, 2025, to be considered for funding. For further inquiries, interested applicants can contact Jerris Raiford at (770) 488-0691 or via email at HRBNOFO@cdc.gov.
    Strengthening comprehensive HIV prevention interventions in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity to strengthen comprehensive HIV prevention interventions in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative aims to reduce new HIV infections through a combination of biomedical, behavioral, and structural interventions, specifically targeting high-risk populations in districts with significant HIV burdens. This program is crucial for addressing health equity and achieving epidemic control in HIV services, with an anticipated funding amount of $5 million for the first year and the expectation of awarding 1-2 grants over a five-year period. Interested applicants, including state and local governments, nonprofits, and foreign entities, must submit their applications by February 18, 2025, and can direct inquiries to Emily Dale at pepfarfoas@cdc.gov.
    Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances." This initiative aims to support research that examines and addresses the systemic and structural factors affecting the awareness, uptake, and adherence to PrEP among substance users, particularly focusing on marginalized populations disproportionately impacted by substance use and HIV. The funding opportunity emphasizes the development, implementation, and evaluation of effective strategies to enhance PrEP persistence, with a total estimated program funding of $500,000 available for multiple awards, and applications are due by March 12, 2025. Interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances." This initiative aims to support research that examines and addresses the systemic and structural factors affecting the awareness, uptake, and adherence to PrEP among individuals who use substances, with a focus on marginalized populations. The funding will provide R34 Planning Grants, allowing for the planning and pilot implementation of innovative strategies to improve PrEP access, with a total estimated program funding of $5 million available for up to eight awards, each capped at $450,000 over a maximum of three years. Interested applicants must submit their proposals by March 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at expanding HIV prevention strategies among populations affected by alcohol use. This initiative encourages research projects that explore the relationship between alcohol consumption and HIV risk behaviors, focusing on areas such as Pre-exposure Prophylaxis (PrEP) utilization, Treatment as Prevention (TasP), and the integration of preventive intervention strategies. The program is particularly significant for addressing health disparities among high-risk groups, including men who have sex with men (MSM) and women with high-risk partners. The NIH anticipates funding between $2 million for 2 to 4 awards, with a project period of up to five years. Interested applicants can submit their proposals through the NIH ASSIST system or Grants.gov, and should direct inquiries to grantsinfo@nih.gov. The application deadline is May 7, 2026.
    Improving HIV prevention and treatment in the Dominican Republic with a focus on priority populations under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at improving HIV prevention and treatment in the Dominican Republic, particularly for priority populations such as Haitian migrants. The initiative seeks to enhance access to HIV testing and treatment, ensure retention in care, and reduce new infections through community outreach and evidence-based interventions, emphasizing collaboration with local health authorities. With an anticipated funding amount of $5.6 million for the first year, the application deadline is set for February 21, 2025, and interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at implementing combination prevention solutions to control the HIV epidemic among high-risk populations in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR). This cooperative agreement seeks to provide targeted interventions, particularly for adolescents aged 10-24, focusing on evidence-based biomedical, behavioral, and structural approaches to reduce new HIV infections and improve health equity. The estimated funding amount for the first year is $25 million, with applications due by February 20, 2025. Interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    Integrated HIV Programs for Tennessee Community-Based Organizations to Support Ending the HIV Epidemic in the United States
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Integrated HIV Programs for Tennessee Community-Based Organizations to Support Ending the HIV Epidemic in the United States." This cooperative agreement aims to implement a comprehensive HIV prevention program that complements existing initiatives, such as the Ryan White program, to prevent new HIV infections and improve health outcomes for individuals living with HIV in Tennessee. Community-based organizations (CBOs) are expected to play a crucial role in enhancing service delivery, increasing HIV diagnosis, and facilitating access to preventive and care services. The estimated total program funding is $20 million, with two awards anticipated, and applications must be submitted electronically by February 11, 2025. For further inquiries, interested parties can contact Erica K. Dunbar at 800-232-4636 or via email at NOFOINFO@cdc.gov.